Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Oligonucleotide analogs having cationic intersubunit linkages
No-Receipt date
2017-03756 - 02/11/2017
No-Filing date
20170402974 - 02/11/2017
No-Granting date
3093988 - 26/01/2018
No-EPO application date
13186973.7 - 10/05/2007
No-EPO granting date
2735568 - 02/08/2017
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
1/2018 - 30/03/2018
Expiration date
11/05/2027
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US43221610/05/2006/US
US43203110/05/2006/US
US43215510/05/2006/US
US43196810/05/2006/US
US43325711/05/2006/US
US799976 P11/05/2006/US
US800145 P11/05/2006/US
US43321311/05/2006/US
US43321411/05/2006/US
US43303311/05/2006/US
US43384011/05/2006/US
US43372411/05/2006/US
US800076 P11/05/2006/US
US800120 P11/05/2006/US
US51805808/09/2006/US
US51775708/09/2006/US
US59516108/11/2006/US
US71557207/03/2007/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07H 19/16
C07H 19/20
C07H 21/00
C12N 15/11
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
836701
SAREPTA THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE, MA 02142
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
2002183
WELLER, DWIGHT D.
2002184
HASSINGER, JED N.
2002185
CAI, BAO
Representatives
Code
Firstname
Surname
Address
Town
Zip
1602
AIKATERINI
SIOTOU
PATISION 122
ATHINA (ATTIKIS)
11257
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4766
AIKATERINI
SIOTOU
PATISION (28IS OKTOVRIOU) 122
ATHINA (ATTIKIS)
11257
GREECE
Owners History
Title Instruments
Payments history
19 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).